An interventional study of Transanal irrigation in Faecal Incontinence and Chronic Constipation, sponsored by Qufora A/S. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Qufora A/S · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This clinical investigation is a post-market, exploratory, randomised, parallel, open-label investigation comparing two UKCA/CE-marked transanal irrigation products for the management of faecal incontinence and/or chronic constipation of heterogenous origin. The aim of this investigation is to assess outcomes in a real-world clinical setting, by following the typical clinical routine, with randomisation and more frequent visits/phone calls as the only difference from typical clinical procedure.
During 4-week training period, participants will trained by nurse specialists on how to use the device to which they were randomised to and will be instructed to irrigate once per day. For the remainder of the investigation, participants will be advised to continue irrigation once daily (or a minimum of 3 times a week). Participants will be followed up via phone call or in-person visit up to 52 weeks.
Qufora A/S is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: Transanal irrigation
Device: Transanal irrigation
Transanal irrigation by use of irrigation devices
Bowel Irrigation Questionnaire (BIQ) 4-point ordinal scale
Participant experience with device (0: strongly disagree, 4: strongly agree)
Time frame: Week 4, 10, 26, and 52
Patient Diary
Bowel irrigation frequency (times per week)
Time frame: Week 10, 26, and 52
Patient Diary
Bowel irrigation volume (in ml)
Time frame: Week 10, 26, and 52
Cleveland Clinic Constipation Score (CCCS)
Constipation severity (Higher scores indicate worse constipation symptoms; score range: 0-30)
Time frame: Week 0, 4, 10, 26, and 52
St Mark's Incontinence Score (SMIS
Fecal incontinence severity (Higher scores indicate worse incontinence symptoms; score range: 0-24)
Time frame: Week 0, 4, 10, 26, and 52
The 5-level EQ-5D (EQ-5D-5L) index score
General health-related quality of life (measure across five dimensions; higher levels indicate greater health impairment)
Time frame: Week 0, 4, 10, 26, and 52
Started Oct 2026 (actual). Primary completion is estimated for Feb 2028, 16 months after the start.
Start moved once since we started tracking on Sep 25, 2026: Aug 2026 → Oct 2026, on Oct 30, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Encopresis